Elsevier

Methods in Enzymology

Volume 187, 1990, Pages 385-394
Methods in Enzymology

[43] Cytochrome P-450 arachidonate oxygenase

https://doi.org/10.1016/0076-6879(90)87045-5Get rights and content

Publisher Summary

The chapter presents a study on cytochrome P-450 arachidonate oxygenase. Cytochrome P-450, the oxygen-activating component of the microsomal electron transport system, is an efficient catalyst for the oxygenated metabolism of arachidonic acid (AA). The chapter mentions that the reaction has an absolute requirement for NADPH and states the procedure of their stoichiometric relationship. The chapter describes methodology utilized in laboratory for the biochemical characterization of the hepatic microsomal AA cytochrome P-450 oxidase as well as its reconstitution utilizing solubilized and purified components of the microsomal electron transport system. In addition to the biochemical advantages of working with a defined system, reconstituted systems are excellent tools for the study of the regioselectivity of AA oxidation by different cytochrome P-450 enzymes. The chapter includes experiment that illustrates the reconstitution of AA oxygenase, utilizing either the major phenobarbital-inducible form of rat liver microsomal cytochrome P-450 or, alternatively, the major ciprofibrate- inducible form. It is shown by the radiochromatograms that the phenobarbital-inducible enzyme is an active epoxygenase, generating four regioisomeric EETs in an enantioselective manner. On the other hand, the ciprofibrate-inducible form catalyzes, almost exclusively, the ω-oxidation of the fatty acid to form 20-hydroxyeicosatetraenoic acid.

References (22)

  • R.H. Weiss et al.

    Arch. Biochem. Biophys.

    (1987)
  • J. Capdevila et al.

    Arch. Biochem. Biophys.

    (1985)
  • J.M. Boeynaems et al.

    Anal. Biochem.

    (1980)
  • N. Chacos et al.

    Biochem. Biophys. Res. Commun.

    (1982)
  • R. Toto et al.

    Biochim. Biophys. Acta

    (1987)
  • E. Oliw

    J. Chromatogr.

    (1985)
  • J.H. Capdevila et al.

    Arch. Biochem. Biophys.

    (1988)
  • J. Capdevila et al.

    Biochem. Biophys. Res. Commun.

    (1981)
  • E. Oliw et al.

    J. Biol. Chem.

    (1982)
  • M. Laniado-Schwartzman et al.

    J. Biol. Chem.

    (1988)
  • Y. Yasukochi et al.

    J. Biol. Chem.

    (1976)
  • Cited by (99)

    • Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase

      2007, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      Subcellular fractions were stored at −80 °C. Arachidonic acid metabolism was assayed by the method of Capdevila et al. [10,28]. Reaction mixtures (0.25 ml total volume) contained 75–150 μg of protein as indicated in the figure legends, and 30 μM [1-14C] arachidonic acid (53 mCi/mmol) (Perkin Elmer, Torrance, CA).

    • Peroxisomal proliferator-activated receptor-α-dependent inhibition of endothelial cell proliferation and tumorigenesis

      2007, Journal of Biological Chemistry
      Citation Excerpt :

      Averaged tumor volumes were calculated using the following formula: tumor volume (mm3) = (length × width2)/2 (37). Western Blot and Immunofluorescence Analyses—Microsomal fractions from mouse liver, temperature-sensitive endothelial, or p60.5 cells were isolated by differential centrifugation as described (38). Microsomal proteins (20–50 μg of protein/well) were resolved by SDS-PAGE in 10% gels and transferred to Immobilon-P membranes (Millipore), and the membranes were incubated with an anti-Cyp2c44 peptide antibody raised against the IGRHQPPSMKDKMKC peptide (GenScript) (39) or rat anti-CYP2C11 antibody (cross-reactive toward mouse Cyp2c29, -2c38, and -2c40, >70% amino acid homology) (40).

    • P450 CYP2C epoxygenase and CYP4A ω-hydroxylase mediate ciprofibrate-induced PPARα-dependent peroxisomal proliferation

      2007, Journal of Lipid Research
      Citation Excerpt :

      For both incubation times, radioactivity was recovered mainly as [1-14C]AA and also in metabolites eluting earlier than EETs (peak X in Fig. 3A–C). Radioactivity in peak X, which presents a retention time corresponding roughly to that of ω/ω-1 hydroxy acids, such as HEETs (26), increased 10–15% in ciprofibrate-treated cells. However, ω/ω-1 hydroxylation is one of the known routes for EET metabolism (45), and peak X probably contains other oxidized metabolites of AA.

    View all citing articles on Scopus
    View full text